Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406055 · ClinicalTrials.gov registry record
CHOICE: Carotid Stenting For High Surgical-Risk Patients
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 18,855
- Enrollment target
NCT00406055 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 18,855 participants.
The verdict
NCT00406055 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 18,855 participants
- Enrollment target
Study Summary
The purposes of this study is to 1) Provide additional information that the commercially available Abbott Vascular Carotid Stent Systems and Embolic Protection Systems can be used successfully by a wide range of physicians under commercial use conditions. 2) Provide an ongoing post-market surveillance mechanism for documentation of clinical outcomes and for possible extension of the Centers for Medicare and Medicaid Services (CMS) coverage to a broader group of patients.
Interventions
- DEVICE RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,855 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00406055
The ClinicalTrials.gov registry entry for NCT00406055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18,855 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 is the first listed.
NCT00406055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00406055 about?
NCT00406055 is a clinical study titled "CHOICE: Carotid Stenting For High Surgical-Risk Patients". The purposes of this study is to 1) Provide additional information that the commercially available Abbott Vascular Carotid Stent Systems and Embolic Protection Systems can be used successfully by a wide range of physicians under commercial use conditions. 2) Provide an ongoing post-market surveillan...
What is the current status of trial NCT00406055?
This trial is currently completed. The enrollment target is 18,855 participants. The study started on 2006-10. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00406055?
The interventions under investigation include: RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 (DEVICE).
Who is sponsoring clinical trial NCT00406055?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.